Join
Live feed
·
PRReleasevia Quantisnow
Albireo Pharma Inc. logo

Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

ByQuantisnow·Wall Street's wire, on your screen.
ALBO· Albireo Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALBO (Albireo Pharma Inc.) and more on Quantisnow.